📰 Marcus News
Page 47 - Marcus News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Marcus. Real-time updates on events, politics, business and more.
September 22, 2023
Editor’s Note: If you are interested in adopting one of these animals, please check with the shelter or rescue to be sure the animal is still available.
September 22, 2023
Daring to be different, Marcus Fulcher stands out in more ways than one for the No. 4-ranked Sacramento State football team.
September 20, 2023
After racist emails are leaked, the two sit down for an interview that's framed like a heavyweight boxing match
September 16, 2023
Shares of Arcus Biosciences, Inc. (NYSE:RCUS – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the nine brokerages that are currently covering the company, Marketbeat reports. One investment analyst has rated the stock with a hold rating and eight have issued a buy rating on the company. The average 1-year […]
September 15, 2023
Editor’s Note: If you are interested in adopting one of these animals, please check with the shelter or rescue to be sure the animal is still available.
September 15, 2023
Paul Dano, Seth Rogen, and America Ferrera game the system in this true-life tale of 21st century class warfare
September 9, 2023
Truist Financial restated their buy rating on shares of Arcus Biosciences (NYSE:RCUS – Free Report) in a report published on Wednesday, Benzinga reports. Truist Financial currently has a $50.00 price target on the stock. Other research analysts also recently issued reports about the stock. Morgan Stanley cut their price objective on shares of Arcus Biosciences […]
September 8, 2023
Arcus Biosciences (NYSE:RCUS – Free Report) had its target price upped by Bank of America from $21.00 to $23.00 in a research note issued to investors on Tuesday morning, MarketBeat Ratings reports. The brokerage currently has a neutral rating on the stock. Other research analysts also recently issued reports about the company. BTIG Research reiterated […]
September 8, 2023
Cantor Fitzgerald reaffirmed their overweight rating on shares of Arcus Biosciences (NYSE:RCUS – Free Report) in a report released on Thursday, Benzinga reports. Cantor Fitzgerald currently has a $46.00 price target on the stock. Several other equities analysts also recently issued reports on RCUS. Mizuho reiterated a buy rating and issued a $51.00 price objective […]
September 8, 2023
In a rapidly evolving world of stock investing, innovative platforms are emerging to meet the growing demand from retail investors. One such platform making waves in the United States is Kappa: Stock Screener. Akylbek Apaitov and Andrew Marcus have combined their expertise to change the way ordinary people invest in stocks.